| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.38 | 0.009 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |